PR

N-lysine methyltransferase KMT5A; PR-Set7; KMT5A; PRSET7; SET8; SETD8

Myeloblastin; AGP7; C-ANCA Antigen; Leukocyte PRoteinase 3; PR-3; PR3; Neutrophil PRoteinase 4; NP-4; P29; Wegener Autoantigen; PRTN3; MBN

Myeloblastin; AGP7; C-ANCA Antigen; Leukocyte PRoteinase 3; PR-3; PR3; Neutrophil PRoteinase 4; NP-4; P29; Wegener Autoantigen; PRTN3; MBN

Myeloblastin; AGP7; Leukocyte PRoteinase 3; PR-3; P29; Wegener autoantigen; MBN

CA; Capsid PRotein; HIV1 Gag p24; Gag polyPRotein; PR55(Gag)

CA; Capsid PRotein; HIV1 Gag p24; Gag polyPRotein; PR55(Gag)

CA; Capsid PRotein; HIV1 Gag p24; Gag polyPRotein; PR55(Gag)

CA; Capsid PRotein; HIV1 Gag p24; Gag polyPRotein; PR55(Gag)

CA; Capsid PRotein; HIV1 Gag p24; Gag polyPRotein; PR55(Gag)

Serine/threonine-PRotein phosphatase 2A 56 kDa regulatory subunit alpha isoform; PP2A B subunit isoform B'-alpha; PP2A B subunit isoform B56-alpha; PP2A B subunit isoform PR61-alpha; PR61alpha; PP2A B subunit isoform R5-alpha; PPP2R5A; Homo sapiens; Human; PR61alpha;

PR domain zinc finger PRotein 2; MTB-ZF; Zinc finger PRotein RIZ; PRDM2; KMT8; RIZ

CA; Capsid PRotein; HIV1 Gag p24; Gag polyPRotein; PR55(Gag)

PR domain zinc finger PRotein 2; MTB-ZF; Zinc finger PRotein RIZ; PRDM2; KMT8; RIZ

PR domain zinc finger PRotein 2; MTB-ZF; Zinc finger PRotein RIZ; PRDM2; KMT8; RIZ

CI-MPR; M6PR; MPR 300; IGF-II receptor; M6P/IGF2R; CD222; MPRI

CI-MPR; M6PR; MPR 300; IGF-II receptor; M6P/IGF2R; CD222; MPRI

CI-MPR; M6PR; MPR 300; IGF-II receptor; M6P/IGF2R; CD222; MPRI

CI-MPR; M6PR; MPR 300; IGF-II receptor; M6P/IGF2R; CD222; MPRI

insulin like growth factor 2 receptor; CI-MPR; M6PR; MPR 300; IGF-II receptor; M6P/IGF2R; CD222; MPRI

Stathmin; Leukemia-Associated PhosphoPRotein p18; Metablastin; OncoPRotein 18; Op18; PhosphoPRotein p19; pp19; PRosolin; PRotein PR22; pp17; STMN1; C1orf215; LAP18; OP18

"Stathmin; Leukemia-Associated PhosphoPRotein p18; Metablastin; OncoPRotein 18; Op18; PhosphoPRotein p19; pp19; PRosolin; PRotein PR22; pp17; STMN1; C1orf215; LAP18; OP18 "

Sphingosine 1-phosphate receptor 2; S1P receptor 2; S1P2; Endothelial differentiation G-PRotein coupled receptor 5; Lysophospholipid receptor B2; Sphingosine 1-phosphate receptor Edg-5 (S1P receptor Edg-5); Edg5; Gpcr13; Lpb2

Apoptosis associated PRotein; GADD 34; Growth arrest and DNA damage inducible 34; Growth arrest and DNA damage-inducible PRotein GADD34; Myeloid differentiation PRimary response PRotein MyD116 homolog; Ppp1r15a; PR15A_HUMAN; PRotein phosphatase 1 regulatory (inhibitor) subunit 15A; PRotein phosphatase 1 regulatory subunit 15A

PGR; NR3C3; PRogesterone receptor; PR; Nuclear receptor subfamily 3 group C member 3

CPRLP; HPRL; hPRL receptor; Lactogen receptor; MFAB; OPR; PR-1; PR-3; PRLR; PRolactin receptor a

PRTN3; ACPA; CANCA

PR; NR3C3

PRogesterone receptor; PR; Nuclear receptor subfamily 3 group C member 3;

MGC45046 antibody; PFM 1 antibody; PFM1 antibody; PR domain containing 4 antibody; PR domain containing PRotein 4 antibody; PR domain zinc finger PRotein 4 antibody; PR domain zinc finger PRotein PFM 1 antibody; PR domain zinc finger PRotein PFM1 antibody; PR domain-containing PRotein 4 antibody; PR/SET domain 4 antibody

PRTN3; MBN; Myeloblastin; AGP7; C-ANCA antigen; Leukocyte PRoteinase 3; PR-3; PR3; Neutrophil PRoteinase 4; NP-4; P29; Wegener autoantigen

ACPA; AGP 7; AGP7; AGP7 serine PRoteinase; Azurophil Granule PRotein 7; C ANCA antigen; C-ANCA antigen; EC 3.4.21.76; Leukocyte PRoteinase 3; MBN; MBT WEGENER AUTOANTIGEN; Myeloblastin; Neutrophil PRoteinase 4; NP 4; NP-4; NP4; P29; PR 3; PR-3; PRoteinase3; PRTN 3; PRtn3; PRTN3_HUMAN; Serine PRoteinase neutrophil Wegener granulomatosis autoantigen; Wegener autoantigen.

PRDM1; BLIMP1; PR domain zinc finger PRotein 1; BLIMP-1; Beta-interferon gene positive regulatory domain I-binding factor; PR domain-containing PRotein 1; Positive regulatory domain I-binding factor 1 (PRDI-BF1; PRDI-binding factor 1)

PRDM1; BLIMP1; PR domain zinc finger PRotein 1; BLIMP-1; Beta-interferon gene positive regulatory domain I-binding factor; PR domain-containing PRotein 1; Positive regulatory domain I-binding factor 1; PRDI-BF1; PRDI-binding factor 1

PGR; NR3C3; PRogesterone receptor; PR; Nuclear receptor subfamily 3 group C member 3

CD MPR; M6PR; Man6PR; MPR46; MPRD; SMPR

SET8; SET07; SETD8; PR-Set7; PR/SET07

SMPR; MPR46; CD-MPR; MPR 46; MPR-46; CD-M6PR

EDG6; LPC1; S1P4; SLP4

SET8; SET07; SETD8; PR-Set7

KMT5A; PR-Set7; SET07; SET8

C1orf215; Lag; LAP 18; LAP18; Leukemia associated phosphoPRotein p18; Leukemia-associated phosphoPRotein p18; Metablastin; OncoPRotein 18; OP 18; Op18; p18; p19; PhosphoPRotein 19; PhosphoPRotein p19; pp17; pp19; PR22; PR22 PRotein; PRosolin; PRotein PR22; SMN; Stathmin; Stathmin1; STMN 1; Stmn1; STMN1_HUMAN

PRotein PR264; Splicing component; 35 kDa; Splicing factor SC35; SC-35; Splicing factor; arginine/serine-rich 2

S1PR1; EDG1; S1P1; ECGF1; EDG-1; CHEDG1; D1S3362

S1PR1; EDG1; S1P1; ECGF1; EDG-1; CHEDG1; D1S3362

S1PR3; EDG3; Sphingosine 1-phosphate receptor 3; S1P receptor 3; S1P3; Endothelial differentiation G-PRotein coupled receptor 3; Sphingosine 1-phosphate receptor Edg-3; S1P receptor Edg-3

High temperature requirement PRotein A2; HTRA 2; HtrA like serine PRotease; HtrA serine peptidase 2; HtrA; E. coli; homolog of; 2; HtrA2; HTRA2_HUMAN; mitochondrial; Omi stress regulated endoPRotease; Omi stress-regulated endoPRotease; PARK 13; PARK13; PR

UBB; Polyubiquitin-B; UBC; Polyubiquitin-C; RPS27A; UBA80; UBCEP1; Ubiquitin-40S ribosomal PRotein S27a; Ubiquitin carboxyl extension PRotein 80; UBA52; UBCEP2; Ubiquitin-60S ribosomal PRotein L40; CEP52; Ubiquitin A-52 residue ribosomal PR; Ubiquitin K48;

XRCC5; G22P2; X-ray repair cross-complementing PRotein 5; 86 kDa subunit of Ku antigen; ATP-dependent DNA helicase 2 subunit 2; ATP-dependent DNA helicase II 80 kDa subunit; CTC box-binding factor 85 kDa subunit; CTC85; CTCBF; DNA repair PR

XRCC5; G22P2; X-ray repair cross-complementing PRotein 5; 86 kDa subunit of Ku antigen; ATP-dependent DNA helicase 2 subunit 2; ATP-dependent DNA helicase II 80 kDa subunit; CTC box-binding factor 85 kDa subunit; CTC85; CTCBF; DNA repair PR

IGF2R; MPRI; Cation-independent mannose-6-phosphate receptor; CI Man-6-P receptor; CI-MPR; M6PR; 300 kDa mannose 6-phosphate receptor; MPR 300; Insulin-like growth factor 2 receptor; Insulin-like growth factor II receptor; IGF-II receptor; M6P/IGF2 receptor; M6P/IGF2R; CD222

c Ki ras2 antibody; c Kirsten ras PRotein antibody; c-K-ras antibody; c-Ki-ras antibody; Cellular c Ki ras2 PRoto oncogene antibody; Cellular transforming PRoto oncogene antibody; CFC2 antibody; cK Ras antibody; GTPase KRas antibody; K RAS p21 PRotein antibody; c Ki ras2 antibody; c Kirsten ras PRotein antibody; c-K-ras antibody; c-Ki-ras antibody; Cellular c Ki ras2 PRoto oncogene antibody; Cellular transforming PRoto oncogene antibody; CFC2 antibody; cK Ras antibody; GTPase KRas antibody; K RAS p21 PRotein antibody; K RAS2A antibody; K RAS2B antibody; K RAS4A antibody; K RAS4B antibody; K-Ras 2 antibody; KI RAS antibody; Ki-Ras antibody; KIRSTEN MURINE SARCOMA VIRUS 2 antibody; Kirsten rat sarcoma 2 viral (v Ki ras2) oncogene homolog antibody; Kirsten rat sarcoma viral oncogene homolog antibody; KRAS antibody; KRAS PRoto oncogene, GTPase antibody; KRAS1 antibody; KRAS2 antibody; N-terminally PRocessed antibody; NS antibody; NS3 antibody; Oncogene KRAS2 antibody; p21ras antibody; PR310 c K ras oncogene antibody; PR310 cK ras oncogene antibody; RALD antibody; RASK_HUMAN antibody; RASK2 antibody; Transforming PRotein p21 antibody; v Ki ras2 Kirsten rat sarcoma 2 viral oncogene homolog antibody; v Ki ras2 Kirsten rat sarcoma viral oncogene homolog antibody;